+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

microRNA Market Share, Size, Trends, Industry Analysis Report, By Product; By Services; By Application; By End-Use; By Regions; Segment Forecast, 2021 - 2028

  • ID: 5397032
  • Report
  • May 2021
  • Region: Global
  • 117 Pages
  • Polaris Market Research

FEATURED COMPANIES

  • BioGenex
  • Horizon Discovery
  • Miltenyi Biotec
  • New England Biolabs
  • QIAGEN
  • SeqMatic LLC
The global microRNA market size is expected to reach USD 3.51 billion by 2028 according to a new study. The report “microRNA Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Consumables); By Services (Service Type, Specimen); By Application (Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease); By End-Use; By Regions; Segment Forecast, 2021 - 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising adoption of microRNA as a biomarker is also driving the market. These biomarkers are particularly important in genome-wide population studies, data-driven methods, as they have the ability to demonstrate high robustness and reproducibility, as compared to traditional procedures. Hence, such molecules serve as a promising drug candidate to develop biomarkers. Moreover, growing interest in liquid-based biopsies has further led to its increased importance in biomarker discovery and further development.

Continuous rise in research activities has also explored the potential of microRNA biomarkers across prognosis, therapeutics, and diagnosis to favor the market expansion in near future. In this direction, in January 2020, research scholars have explored the presence of microRNA in the peripheral blood vessel as a biomarker to diagnose bipolar II disorder using NGS. These microRNAs could serve as a possible non-invasive solution to diagnose any indication of neurodegenerative disorders.

The cardiovascular segment is projected to witness a lucrative market growth rate over the assessment period. This is primarily due to the introduction of novel biomarkers for early diagnosis of heart-related ailments, and significant investments in the sector.

microRNAs are presumed to be an attractive option for cardiovascular therapeutics due to their several benefits such as tissue-specific expressions, secretion of body fluids, and stability. Moreover, many studies gave also pointed to the role of microRNAs in the regulation of lipoprotein metabolism, hypertension, blood pressure, and even progression of adjacent co-morbidities.

Asia Pacific market is projected to witness a lucrative growth rate over the microRNA study period. The growth in the region is primarily due to advancements in genomics and proteomics in genomic studies and the rapid adoption of new tools supporting research goals.

For instance, in March 2021, researchers based in Chinese universities have identified blood microRNA as a potential biomarker for hepatic sinusoidal obstruction syndrome via microarray-based profiling. In addition, a market study has also paved several computational tools to predict the relation between miRNA and its target microRNA.

Market participants operating in the microRNA industry include Merck KgaA, Thermo Fisher, BioGenex, New England Biolabs, Horizon Discovery, GeneCopoeia, Quantabio, NanoString, SeqMatic LLC, Sistemic Scotland Limited, Synlogic, QIAGEN, Miltenyi Biotec, Biodynamics Laboratory Inc., OriGene Technologies.

The publisher has segmented the microRNAs market report on the basis of product, services, application, end-use and region:

microRNA, Product Outlook (Revenue - USD Million, 2016 - 2028)

  • Instruments
  • Consumables

microRNA, Services Outlook (Revenue - USD Million, 2016 - 2028)

  • Service Type
  • Isolation & Purification
  • miRNA cDNA Synthesis
  • Profiling, Localization, & Quantification
  • Functional Analysis
  • Others
  • Specimen
  • Whole Blood
  • Serum
  • Plasma
  • FFPE
  • Fresh Frozen Tissue
  • Others

microRNA, Application Outlook (Revenue - USD Million, 2016 - 2028)

  • Cancer
  • Infectious Diseases
  • Immunological Disorder
  • Cardiovascular Disease
  • Neurological Disease
  • Others

microRNA, End Use Outlook (Revenue - USD Million, 2016 - 2028)

  • Biotechnology & Pharmaceutical Companies
  • Academic & Government Research Institutes
  • Others

microRNA, by Regional Outlook (Revenue - USD Million, 2016 - 2028)

  • North America
  • US
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Spain
  • Netherlands
  • Austria
  • Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • South Korea
  • Indonesia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • BioGenex
  • Horizon Discovery
  • Miltenyi Biotec
  • New England Biolabs
  • QIAGEN
  • SeqMatic LLC
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary
2.1. Market Highlights

3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Products
3.2.1. Primary Products
3.2.2. Secondary Products

4. microRNA Market Insights
4.1. microRNA - Industry snapshot
4.2. microRNA Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Wide adoption of microRNA tools
4.2.1.2. Disease associated applications
4.2.2. Restraints and Challenges
4.2.2.1. Scalability issues
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. microRNA Market Industry trends
4.6. COVID-19 Impact Analysis

5. microRNA Market Assessment by Product
5.1. Key Findings
5.2. Introduction
5.2.1. Global microRNA Market, By Product, 2016 - 2028 (USD Million)
5.3. Instruments
5.3.1. Global microRNA Market, by Instruments, by Region, 2016- 2028 (USD Million)
5.4. Consumables
5.4.1. Global microRNA Market, by Consumables, by Region, 2016- 2028 (USD Million)

6. Global microRNA Market, by Services
6.1. Key Findings
6.2. Introduction
6.2.1. Global microRNA Market, By Service Type, 2016 - 2028 (USD Million)
6.3. Service Type
6.3.1. Global microRNA Market, by Powder, By Region, 2016- 2028 (USD Million)
6.3.2. Isolation & Purification
6.3.2.1. Isolation & Purification Market, By Region, 2016- 2028 (USD Million)
6.3.3. miRNA cDNA Synthesis
6.3.3.1. miRNA cDNA Synthesis Market, By Region, 2016- 2028 (USD Million)
6.3.4. Profiling, Localization, & Quantification
6.3.4.1. Profiling, Localization, & Quantification Market, By Region, 2016- 2028 (USD Million)
6.3.5. Functional Analysis
6.3.5.1. Functional Analysis Market, By Region, 2016- 2028 (USD Million)
6.3.6. Others
6.3.6.1. Other Services Market, By Region, 2016- 2028 (USD Million)
6.4. Specimen
6.4.1. Global microRNA Market, by Specimen, by Region, 2016- 2028 (USD Million)
6.4.2. Whole Blood
6.4.2.1. Whole Blood Specimen Market, By Region, 2016- 2028 (USD Million)
6.4.3. Serum
6.4.3.1. Serum Specimen Market, By Region, 2016- 2028 (USD Million)
6.4.4. Plasma
6.4.4.1. Plasma Specimen Market, By Region, 2016- 2028 (USD Million)
6.4.5. FFPE
6.4.5.1. FFPE Market, By Region, 2016- 2028 (USD Million)
6.4.6. Fresh Frozen Tissue
6.4.6.1. Fresh Frozen Tissue Market, By Region, 2016- 2028 (USD Million)
6.4.7. Others
6.4.7.1. Others Market, By Region, 2016- 2028 (USD Million)

7. Global microRNA Market, by End Use
7.1. Key Findings
7.2. Introduction
7.2.1. Global microRNA Market, By End Use, 2016 - 2028 (USD Million)
7.3. Biotechnology & Pharmaceutical Companies
7.3.1. Global microRNA Market, by Biotechnology & Pharmaceutical Companies, By Region, 2016- 2028 (USD Million)
7.4. Academic & Government Research Institutes
7.4.1. Global microRNA Market, by Academic & Government Research Institutes, by Region, 2016- 2028 (USD Million)
7.5. Other end-users
7.5.1. Global microRNA Market, by Other end-users, by Region, 2016- 2028 (USD Million)

8. microRNA Market Assessment by Application
8.1. Key Findings
8.2. Introduction
8.2.1. Global microRNA Market, By Application, 2016 - 2028 (USD Million)
8.3. Cancer
8.3.1. Global microRNA Market, by Cancer, by Region, 2016- 2028 (USD Million)
8.4. Infectious Diseases
8.4.1. Global microRNA Market, by Infectious Diseases, by Region, 2016- 2028 (USD Million)
8.5. Immunological Disorder
8.5.1. Global microRNA Market, by Immunological Disorder, by Region, 2016- 2028 (USD Million)
8.6. Cardiovascular Disease
8.6.1. Global microRNA Market, by Cardiovascular Disease, by Region, 2016- 2028 (USD Million)
8.7. Neurological Disease
8.7.1. Global microRNA Market, by Neurological Disease, by Region, 2016- 2028 (USD Million)
8.8. Others
8.8.1. Global microRNA Market, by Others, by Region, 2016- 2028 (USD Million)

9. microRNA Market Assessment by Geography
9.1. Key findings
9.2. Introduction
9.2.1. microRNA Market Assessment, By Geography, 2016- 2028 (USD Million)
9.3. microRNA Market - North America
9.3.1. North America: microRNA Market, By Product, 2016- 2028 (USD Million)
9.3.2. North America: microRNA Market, By Service Type, 2016- 2028 (USD Million)
9.3.3. North America: microRNA Market, By End Use, 2016 - 2028 (USD Million)
9.3.4. North America: microRNA Market, By Application, 2016- 2028 (USD Million)
9.3.5. microRNA Market - U.S.
9.3.5.1. U.S.: microRNA Market, By Product, 2016- 2028 (USD Million)
9.3.5.2. U.S.: microRNA Market, By Service Type, 2016- 2028 (USD Million)
9.3.5.3. U.S.: microRNA Market, By End Use, 2016- 2028 (USD Million)
9.3.5.4. U.S.: microRNA Market, By Application, 2016- 2028 (USD Million)
9.3.6. microRNA Market - Canada
9.3.6.1. Canada: microRNA Market, By Product, 2016- 2028 (USD Million)
9.3.6.2. Canada.: microRNA Market, By Service Type, 2016- 2028 (USD Million)
9.3.6.3. Canada: microRNA Market, By End Use, 2016- 2028 (USD Million)
9.3.6.4. Canada: microRNA Market, By Application, 2016- 2028 (USD Million)
9.4. microRNA Market - Europe
9.4.1. Europe: microRNA Market, By Product, 2016- 2028 (USD Million)
9.4.2. Europe.: microRNA Market, By Service Type, 2016- 2028 (USD Million)
9.4.3. Europe: microRNA Market, By End Use, 2016- 2028 (USD Million)
9.4.4. Europe: microRNA Market, By Application, 2016- 2028 (USD Million)
9.4.5. microRNA Market - UK
9.4.5.1. UK: microRNA Market, By Product, 2016- 2028 (USD Million)
9.4.5.2. UK.: microRNA Market, By Service Type, 2016- 2028 (USD Million)
9.4.5.3. UK: microRNA Market, By End Use, 2016- 2028 (USD Million)
9.4.5.4. UK: microRNA Market, By Application, 2016- 2028 (USD Million)
9.4.6. microRNA Market - France
9.4.6.1. France: microRNA Market, By Product, 2016- 2028 (USD Million)
9.4.6.2. France.: microRNA Market, By Service Type, 2016- 2028 (USD Million)
9.4.6.3. France: microRNA Market, By End Use, 2016- 2028 (USD Million)
9.4.6.4. France: microRNA Market, By Application, 2016- 2028 (USD Million)
9.4.7. microRNA Market - Germany
9.4.7.1. Germany: microRNA Market, By Product, 2016- 2028 (USD Million)
9.4.7.2. Germany.: microRNA Market, By Service Type, 2016- 2028 (USD Million)
9.4.7.3. Germany: microRNA Market, By End Use, 2016- 2028 (USD Million)
9.4.7.4. Germany: microRNA Market, By Application, 2016- 2028 (USD Million)
9.4.8. microRNA Market - Italy
9.4.8.1. Italy: microRNA Market, By Product, 2016- 2028 (USD Million)
9.4.8.2. Italy.: microRNA Market, By Service Type, 2016- 2028 (USD Million)
9.4.8.3. Italy: microRNA Market, By End Use, 2016- 2028 (USD Million)
9.4.8.4. Italy: microRNA Market, By Application, 2016- 2028 (USD Million)
9.4.9. microRNA Market - Spain
9.4.9.1. Spain: microRNA Market, By Product, 2016- 2028 (USD Million)
9.4.9.2. Spain.: microRNA Market, By Service Type, 2016- 2028 (USD Million)
9.4.9.3. Spain: microRNA Market, By End Use, 2016- 2028 (USD Million)
9.4.9.4. Spain: microRNA Market, By Application, 2016- 2028 (USD Million)
9.4.10. microRNA Market - Netherlands
9.4.10.1. Netherlands: microRNA Market, By Product, 2016- 2028 (USD Million)
9.4.10.2. Netherlands.: microRNA Market, By Service Type, 2016- 2028 (USD Million)
9.4.10.3. Netherlands: microRNA Market, By End Use, 2016- 2028 (USD Million)
9.4.10.4. Netherlands: microRNA Market, By Application, 2016- 2028 (USD Million)
9.4.11. microRNA Market - Austria
9.4.11.1. Austria: microRNA Market, By Product, 2016- 2028 (USD Million)
9.4.11.2. Austria.: microRNA Market, By Service Type, 2016- 2028 (USD Million)
9.4.11.3. Austria: microRNA Market, By End Use, 2016- 2028 (USD Million)
9.4.11.4. Austria: microRNA Market, By Application, 2016- 2028 (USD Million)
9.5. microRNA Market - Asia-Pacific
9.5.1. Asia Pacific: microRNA Market, By Product, 2016- 2028 (USD Million)
9.5.2. Asia Pacific.: microRNA Market, By Service Type, 2016- 2028 (USD Million)
9.5.3. Asia-pacific: microRNA Market, By End Use, 2016- 2028 (USD Million)
9.5.4. Asia-pacific: microRNA Market, By Application, 2016- 2028 (USD Million)
9.5.5. microRNA Market - China
9.5.5.1. China: microRNA Market, By Product, 2016- 2028 (USD Million)
9.5.5.2. China.: microRNA Market, By Service Type, 2016- 2028 (USD Million)
9.5.5.3. China: microRNA Market, By End Use, 2016- 2028 (USD Million)
9.5.5.4. China: microRNA Market, By Application, 2016- 2028 (USD Million)
9.5.6. microRNA Market - India
9.5.6.1. India: microRNA Market, By Product, 2016- 2028 (USD Million)
9.5.6.2. India.: microRNA Market, By Service Type, 2016- 2028 (USD Million)
9.5.6.3. India: microRNA Market, By End Use, 2016- 2028 (USD Million)
9.5.6.4. India: microRNA Market, By Application, 2016- 2028 (USD Million)
9.5.7. microRNA Market - Malaysia
9.5.7.1. Malaysia: microRNA Market, By Product, 2016- 2028 (USD Million)
9.5.7.2. Malaysia.: microRNA Market, By Service Type, 2016- 2028 (USD Million)
9.5.7.3. Malaysia: microRNA Market, By End Use, 2016- 2028 (USD Million)
9.5.7.4. Malaysia: microRNA Market, By Application, 2016- 2028 (USD Million)
9.5.8. microRNA Market - Japan
9.5.8.1. Japan: microRNA Market, By Product, 2016- 2028 (USD Million)
9.5.8.2. Japan.: microRNA Market, By Service Type, 2016- 2028 (USD Million)
9.5.8.3. Japan: microRNA Market, By End Use, 2016- 2028 (USD Million)
9.5.8.4. Japan: microRNA Market, By Application, 2016- 2028 (USD Million)
9.5.9. microRNA Market - Indonesia
9.5.9.1. Indonesia: microRNA Market, By Product, 2016- 2028 (USD Million)
9.5.9.2. Indonesia.: microRNA Market, By Service Type, 2016- 2028 (USD Million)
9.5.9.3. Indonesia: microRNA Market, By End Use, 2016- 2028 (USD Million)
9.5.9.4. Indonesia: microRNA Market, By Application, 2016- 2028 (USD Million)
9.5.10. microRNA Market - South Korea
9.5.10.1. South Korea: microRNA Market, By Product, 2016- 2028 (USD Million)
9.5.10.2. South Korea.: microRNA Market, By Service Type, 2016- 2028 (USD Million)
9.5.10.3. South Korea: microRNA Market, By End Use, 2016- 2028 (USD Million)
9.5.10.4. South Korea: microRNA Market, By Application, 2016- 2028 (USD Million)
9.6. microRNA Market - Middle East & Africa
9.6.1. Middle East & Africa: microRNA Market, By Product, 2016- 2028 (USD Million)
9.6.2. Middle East & Africa.: microRNA Market, By Service Type, 2016- 2028 (USD Million)
9.6.3. Middle East & Africa: microRNA Market, By End Use, 2016- 2028 (USD Million)
9.6.4. Middle East & Africa: microRNA Market, By Application, 2016- 2028 (USD Million)
9.6.5. microRNA Market - Saudi Arabia
9.6.5.1. Saudi Arabia: microRNA Market, By Product, 2016- 2028 (USD Million)
9.6.5.2. Saudi Arabia.: microRNA Market, By Service Type, 2016- 2028 (USD Million)
9.6.5.3. Saudi Arabia: microRNA Market, By End Use, 2016- 2028 (USD Million)
9.6.5.4. Saudi Arabia: microRNA Market, By Application, 2016- 2028 (USD Million)
9.6.6. microRNA Market - UAE
9.6.6.1. UAE: microRNA Market, By Product, 2016- 2028 (USD Million)
9.6.6.2. UAE.: microRNA Market, By Service Type, 2016- 2028 (USD Million)
9.6.6.3. UAE: microRNA Market, By End Use, 2016- 2028 (USD Million)
9.6.6.4. UAE: microRNA Market, By Application, 2016- 2028 (USD Million)
9.6.7. microRNA Market - Israel
9.6.7.1. Israel: microRNA Market, By Product, 2016- 2028 (USD Million)
9.6.7.2. Israel.: microRNA Market, By Service Type, 2016- 2028 (USD Million)
9.6.7.3. Israel: microRNA Market, By End Use, 2016- 2028 (USD Million)
9.6.7.4. Israel: microRNA Market, By Application, 2016- 2028 (USD Million)
9.6.8. microRNA Market - South Africa
9.6.8.1. South Africa: microRNA Market, By Product, 2016- 2028 (USD Million)
9.6.8.2. South Africa.: microRNA Market, By Service Type, 2016- 2028 (USD Million)
9.6.8.3. South Africa: microRNA Market, By End Use, 2016- 2028 (USD Million)
9.6.8.4. South Africa: microRNA Market, By Application, 2016- 2028 (USD Million)
9.7. microRNA Market - Latin America
9.7.1. Latin America: microRNA Market, By Product, 2016- 2028 (USD Million)
9.7.2. Latin America.: microRNA Market, By Service Type, 2016- 2028 (USD Million)
9.7.3. Latin America: microRNA Market, By End Use, 2016- 2028 (USD Million)
9.7.4. Latin America: microRNA Market, By Application, 2016- 2028 (USD Million)
9.7.5. microRNA Market - Mexico
9.7.5.1. Mexico: microRNA Market, By Product, 2016- 2028 (USD Million)
9.7.5.2. Mexico.: microRNA Market, By Service Type, 2016- 2028 (USD Million)
9.7.5.3. Mexico: microRNA Market, By End Use, 2016- 2028 (USD Million)
9.7.5.4. Mexico: microRNA Market, By Application, 2016- 2028 (USD Million)
9.7.6. microRNA Market - Brazil
9.7.6.1. Brazil: microRNA Market, By Product, 2016- 2028 (USD Million)
9.7.6.2. Brazil.: microRNA Market, By Service Type, 2016- 2028 (USD Million)
9.7.6.3. Brazil: microRNA Market, By End Use, 2016- 2028 (USD Million)
9.7.6.4. Brazil: microRNA Market, By Application, 2016- 2028 (USD Million)
9.7.7. microRNA Market - Argentina
9.7.7.1. Argentina: microRNA Market, By Product, 2016- 2028 (USD Million)
9.7.7.2. Argentina.: microRNA Market, By Service Type, 2016- 2028 (USD Million)
9.7.7.3. Argentina: microRNA Market, By End Use, 2016- 2028 (USD Million)
9.7.7.4. Argentina: microRNA Market, By Application, 2016- 2028 (USD Million)

10. Competitive Landscape
10.1. Expansion and Acquisition Analysis
10.1.1. Expansion
10.1.2. Acquisition
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles
11.1. Thermo Fisher Scientific
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product & Services Benchmarking
11.1.4. Recent Development
11.2. Horizon Discovery Group plc.
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product & Services Benchmarking
11.2.4. Recent Development
11.3. Synlogic
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product & Services Benchmarking
11.3.4. Recent Development
11.4. GeneCopoeia, Inc.
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product & Services Benchmarking
11.4.4. Recent Development
11.5. New England Biolabs
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product & Services Benchmarking
11.5.4. Recent Development
11.6. Quantabio
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product & Services Benchmarking
11.6.4. Recent Development
11.7. Merck KGaA
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product & Services Benchmarking
11.7.4. Recent Development
11.8. QIAGEN
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product & Services Benchmarking
11.8.4. Recent Development
Note: Product cover images may vary from those shown
  • Merck KgaA
  • Thermo Fisher
  • BioGenex
  • New England Biolabs
  • Horizon Discovery
  • GeneCopoeia
  • Quantabio
  • NanoString
  • SeqMatic LLC
  • Sistemic Scotland Limited
  • Synlogic
  • QIAGEN
  • Miltenyi Biotec
  • Biodynamics Laboratory Inc.
  • OriGene Technologies.
Note: Product cover images may vary from those shown